Shire plc, SHPG is in the exchange NASDAQ and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in Ireland, Shire plc, SHPG has a market cap of 59688.5. Since its IPO date on the 3/25/1998, Shire plc, SHPG performance year to date is -6.30%. Today Shire plc, SHPG has gained -0.60%, with a current price of 191.15.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 24.50%. The management of the company have seen the company have a payout ratio of 20.20%. Return of assets are at 3.10%, with return on investment at 12.00%.
In terms of debt levels and profit levels, Shire plc, SHPG is seeing a long-term debt/equity of 0.72. While Total debt/equity is 0.81. With a profit margin of 13.20%, this is combined with a gross margin of 79.50%, and operating margin of 19.30%. Shire plc ability to meet debt levels, with a current ratio of 1.4, while the quick ratio is 0.6.
For the last year Shire plc, SHPG has seen a EPS growth of -59.40%. A performance for the year of -13.22%. The 52-week high is -16.96%, and the 52-week low is 30.14%. The average volume for Shire plc, SHPG is 616100.
With a target price of 252.54, can Shire plc, SHPG reach this target? Looking at the value indicators of Shire plc, SHPG. Shire plc has a P/E of 30.36 and a forward P/E of 12.56. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.12. Shire plc also has a P/S and a P/B of 7.95 and 1.46 respectively. For P/cash, Shire plc has a value of 86.08, while it is *TBA for P/free cash flow.
At the current price of 191.15, Shire plc has a dividend yield of 0.42%. We see a return on equity of 6.70%.
Looking more long-term Shire plc, is projected to get an EPS growth for the next five years of 14.30%. In the short-term an EPS growth of 17.72% in the next year is forecasted. This is after a EPS growth of -59.40% for this year and for the last five years a 16.50% growth has been seen.